Kellerhals Carrard advised TecMed on the deal, while Walder Wyss advised Ypsomed. TecMed is taking a step towards becoming a global diabetes care leader fully focused...
TecMed AG’s CHF420 Million Acquisition Of Ypsomed Diabetes Care AG
Rhenopharma Group’s Acquisition Of Kenopharma AG
Kellerhals Carrard advised Rhenopharma Group in this acquisition. Rhenopharma Group, a leading service provider in the pharmaceutical sector headquartered in Basel, acquired Konapharma AG, a contract...


























